Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ballantyne

Showing results (131-140 of 999) with videos related to

Pageof 100
Sort By:
Journal of Lipid Research|August 17, 2012
Interaction between SNPs in the RXRA and near ANGPTL3 gene region inhibits apoB reduction after statin-fenofibric acid therapy in individuals with mixed dyslipidemiaLi Ma, Christie M Ballantyne, John W Belmont, et al.
Metabolism: Clinical and Experimental|March 1, 1987
Low-density lipoprotein metabolism in cerebrotendinous xanthomatosisC M Ballantyne, G L Vega, C East, et al.
Biological Research for Nursing|March 3, 2009
Inflammatory protein levels and depression screening after coronary stenting predict major adverse coronary eventsLorraine Frazier, William K Vaughn, James T Willerson, et al.
Statistics in Biosciences|February 23, 2010
Improved Horvitz-Thompson Estimation of Model Parameters from Two-phase Stratified Samples: Applications in EpidemiologyNorman E Breslow, Thomas Lumley, Christie M Ballantyne, et al.
Vascular Health and Risk Management|July 28, 2022
PCSK9 Inhibitors in the Management of Cardiovascular Risk: A Practical GuidanceXiaoming Jia, Mahmoud Al Rifai, Anum Saeed, et al.
Circulation Research|May 23, 2001
Novel polymorphisms in promoter region of atp binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapyS Lutucuta, C M Ballantyne, H Elghannam, et al.
The Journal of Experimental Medicine|November 23, 2006
Intraluminal crawling of neutrophils to emigration sites: a molecularly distinct process from adhesion in the recruitment cascadeMia Phillipson, Bryan Heit, Pina Colarusso, et al.
American Journal of Preventive Cardiology|April 22, 2024
High lipoprotein(a): Actionable strategies for risk assessment and mitigationGissette Reyes-Soffer, Calvin Yeang, Erin D Michos, et al.
The American Journal of Cardiology|March 21, 2003
Efficacy of rosuvastatin 10 mg in patients with the metabolic syndromeChristie M Ballantyne, Evan A Stein, Rodolfo Paoletti, et al.
Journal of Clinical Lipidology|February 5, 2011
Effects of prescription omega-3-acid ethyl esters on lipoprotein particle concentrations, apolipoproteins AI and CIII, and lipoprotein-associated phospholipase A(2) mass in statin-treated subjects with hypertriglyceridemiaMichael H Davidson, Kevin C Maki, Harold Bays, et al.
Pageof 100

Showing results (131-140 of 999) with videos related to

Sort By:
Pageof 100
Journal of Lipid Research|August 17, 2012
Interaction between SNPs in the RXRA and near ANGPTL3 gene region inhibits apoB reduction after statin-fenofibric acid therapy in individuals with mixed dyslipidemiaLi Ma, Christie M Ballantyne, John W Belmont, et al.
Metabolism: Clinical and Experimental|March 1, 1987
Low-density lipoprotein metabolism in cerebrotendinous xanthomatosisC M Ballantyne, G L Vega, C East, et al.
Biological Research for Nursing|March 3, 2009
Inflammatory protein levels and depression screening after coronary stenting predict major adverse coronary eventsLorraine Frazier, William K Vaughn, James T Willerson, et al.
Statistics in Biosciences|February 23, 2010
Improved Horvitz-Thompson Estimation of Model Parameters from Two-phase Stratified Samples: Applications in EpidemiologyNorman E Breslow, Thomas Lumley, Christie M Ballantyne, et al.
Vascular Health and Risk Management|July 28, 2022
PCSK9 Inhibitors in the Management of Cardiovascular Risk: A Practical GuidanceXiaoming Jia, Mahmoud Al Rifai, Anum Saeed, et al.
Circulation Research|May 23, 2001
Novel polymorphisms in promoter region of atp binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapyS Lutucuta, C M Ballantyne, H Elghannam, et al.
The Journal of Experimental Medicine|November 23, 2006
Intraluminal crawling of neutrophils to emigration sites: a molecularly distinct process from adhesion in the recruitment cascadeMia Phillipson, Bryan Heit, Pina Colarusso, et al.
American Journal of Preventive Cardiology|April 22, 2024
High lipoprotein(a): Actionable strategies for risk assessment and mitigationGissette Reyes-Soffer, Calvin Yeang, Erin D Michos, et al.
The American Journal of Cardiology|March 21, 2003
Efficacy of rosuvastatin 10 mg in patients with the metabolic syndromeChristie M Ballantyne, Evan A Stein, Rodolfo Paoletti, et al.
Journal of Clinical Lipidology|February 5, 2011
Effects of prescription omega-3-acid ethyl esters on lipoprotein particle concentrations, apolipoproteins AI and CIII, and lipoprotein-associated phospholipase A(2) mass in statin-treated subjects with hypertriglyceridemiaMichael H Davidson, Kevin C Maki, Harold Bays, et al.
Pageof 100